DDJ Patient Article · As of March 2026 · Explained Simply
How robust is the link between periodontitis and cardiovascular risk, and what does it mean for dental practice?
Explained clearly based on current scientific studies. This article helps you make informed decisions with your dentist.
This article looks at a substance or influence and what research says about its possible effects.
Quick and Clear
The most important findings at a glance:
- The results are mixed—there is both positive and critical evidence.
- The scientific basis is solid, but not all questions have been definitively settled.
- It is important to distinguish between epidemiological signal and clinical evidence.
- Treating gum disease (periodontitis) is always worthwhile—but not because it protects the heart, but because it protects the teeth.
Why is this topic important for you?
You may have heard that there are differing opinions on this topic. This is because science is often more complex than a simple yes or no answer suggests. In this article, we explain what the current research actually shows—without technical jargon and without omitting important details.
The link between gum health and cardiovascular health is real, but the question of causality remains largely open. The question is what dentists can clinically derive from this.
Why is that important for you? Because as a patient, you can make better decisions when you understand the background. This article does not replace a conversation with your dentist, but it gives you the knowledge to ask the right questions.
In research, the most important questions revolve around the following areas: Association vs. Causality, Biological Plausibility, and Clinical Consequence for Dentistry. In the following sections, we explain what the studies say about each of these areas and what that means for your daily life.
What matters more: Association or Causality?
A common patient question is how to weigh association vs. causality. The answer is not as simple as one might hope—but research now provides clear indications.
Noites et al. (2022) conducted a systematic review and meta-analysis of several studies, including 15 observational studies (8 cross-sectional studies, 5 case-control studies, 2 longitudinal cohort studies), which included a total of 673,083 adults with a mean age of 41 to 66 years. In the cross-sectional studies, apical gum disease (periodontitis) was significantly associated with cardiovascular diseases (pooled OR 1.53; 95% CI 1.02–2.29; p = 0.039), but the heterogeneity was considerable (I² = 75.0%; p < 0.001).
The pooled odds ratio from the five case-control studies showed no significant association (OR 1.24; 95% CI 0.67–2.29; p = 0.494; I² = 82.1%). Similarly, the pooled risk ratio from the two longitudinal cohort studies was not significant (RR 1.27; 95% CI 0.71–2.27; p = 0.413; I² = 69.1%). The authors emphasized that the inconsistent results across study designs and the considerable heterogeneity warrant caution when interpreting the findings.
The sensitivity analysis showed that the association in cross-sectional studies was non-significant when individual studies with high OR were removed. Meta-regressions indicated that age and male proportion did not influence the association. Publication bias was detectable in cross-sectional studies (Egger test p = 0.001), but not in case-control studies (p = 0.147).
The individual study results varied considerably: An et al. (2016) found a 5.3-fold increased risk, while other studies showed an OR below 1, which would suggest a protective effect of gum disease (periodontitis). This extreme variation underscores the methodological fragility of the scientific basis and susceptibility to confounding factors.
Methodologically, it must be noted that the included studies vary considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of the results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the basic statement.
For dental practice, the current research status means: The association is real, but the causal proof is lacking. Communicating periodontal disease (periodontitis) as an independent cardiovascular risk factor overreaches the available scientific evidence. The correct statement is: Periodontal disease (periodontitis) is associated with a slightly increased cardiovascular risk, but whether treating the periodontal disease (periodontitis) lowers the cardiovascular risk is not proven.
The clinical consequence is paradoxically clear, even if the question of causality remains open: Periodontitis therapy is always indicated for dental reasons, regardless of any potential cardiovascular benefit.
In daily practice, this means: The scientific evidence does not provide a one-size-fits-all answer but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be considered in the decision.
What does this mean for you? It is important to distinguish between epidemiological signal and clinical evidence.
You may encounter this topic more often in daily life than you think. What is important here: Not every report you find in the media or on the internet accurately reflects the state of research. The studies show a more nuanced picture than sensational headlines suggest.
Science has intensively investigated this topic in recent years. For this article, more than 10 scientific papers were evaluated. It is important to understand that not every study has the same weight of evidence. Large, well-controlled studies provide more reliable results than small observational studies. The overall picture from these various studies is what we present to you here.
💡 What does this mean for you?
It is important to distinguish between epidemiological signal and clinical evidence. Discuss with your next dentist appointment what this specifically means for your situation.
What does "Biological Plausibility" mean for me as a patient?
When it comes to biological plausibility, the research status is clearer than many think. Here you will learn what current studies actually show.
Lu et al. (2024) investigated the role of periodontal disease (periodontitis) in the development of atherosclerotic cardiovascular diseases (ASCVD) in patients with components of metabolic syndrome in a systematic review and meta-analysis of 19 studies (11 long-term observational studies, 4 case-control studies, 4 cross-sectional studies). The meta-analysis of 15 studies showed significantly increased risks for all four MetS components: dysglycemia (RR 1.25; 95% CI 1.13–1.37), obesity (RR 1.13; 95% CI 1.02–1.24), dyslipidemia (RR 1.36; 95% CI 1.13–1.65), and hypertension (RR 1.20; 95% CI 1.05–1.36).
The biological plausibility is supported by the common inflammatory mechanism: Periodontal disease (periodontitis) as chronic inflammation causes persistent low-grade inflammation, which can promote endothelial dysfunction and atherogenesis through elevated systemic inflammatory markers (CRP, TNF-alpha, IL-6). Lu et al. (2024) argue that periodontal disease (periodontitis) could exacerbate the development of ASCVD in MetS patients via this systemic inflammatory pathway.
Wu et al. (2024) supplemented the scientific evidence with a meta-analysis of six long-term observational studies on the association between periodontal disease (periodontitis) and mortality in patients with chronic kidney disease (CKD). The pooled analysis showed a significant association with cardiovascular mortality (adjusted HR 1.57; 95% CI 1.08–2.27; I² = 34.0 %) and a non-significant association with all-cause mortality (adjusted HR 1.24; 95% CI 0.89–1.72; I² = 80.9 %). The mortality rate was 44.8 % for patients with periodontal disease (periodontitis) versus 28.0 % for controls.
Larsson and Burgess (2022) provided an important contribution to the causality discussion in their MR meta-analysis of several studies: Genetic predisposition to smoking was causally associated with an increased risk for 13 of 14 cardiovascular diseases and separately with periodontal disease (periodontitis). This common causal exposure to smoking could explain a significant part of the observed periodontitis-related-cardiovascular association, without requiring a direct causal pathway from periodontal disease (periodontitis) to heart disease.
Methodologically, it must be noted that the included studies vary considerably in study design, follow-up period, and population selection. This heterogeneity limits the comparability of the results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the core statement.
The biological plausibility exists, but plausibility is not causal proof. The systemic inflammation hypothesis is the strongest mechanistic link between gum disease (periodontitis) and cardiovascular risk, but common risk factors such as smoking, diabetes, and socioeconomic status could also explain the association.
For clinical communication, the distinction between a risk interpreter and a risk communicator is crucial: The practitioner should know the biological plausibility but must not give the patient the impression that periodontitis therapy is an established cardiovascular preventive measure.
In daily practice, this means: The scientific evidence does not provide a one-size-fits-all answer but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must be incorporated into the decision.
What does this mean for you? Plausibility is not proof—It is important to be precise here.
You may encounter this topic more often in daily life than you think. What is important here: Not every report you find in the media or on the internet accurately reflects the state of research. The studies show a more nuanced picture than general headlines suggest.
How do scientists arrive at these statements? They do not evaluate just one study but look at many investigations simultaneously. This allows them to determine whether a result was random or if it is consistently confirmed. In this case, the findings are based on 10 scientific papers from different countries and research groups.
💡 What does this mean for you?
Plausibility is not proof—It is important to be precise here. Discuss this with your dentist at your next visit what this specifically means for your situation.
What does "Clinical Consequence for Dentistry" mean for me as a patient?
One point that often causes uncertainty is clinical consequence for dentistry. However, science has made important progress in recent years.
The available scientific evidence from four meta-analyses of multiple studies (Noites et al. 2022; Wu et al. 2024; Lu et al. 2024; Larsson and Burgess 2022) converges on a consistent finding: gum disease (periodontitis) is associated with a slightly to moderately increased cardiovascular risk, but it is not a confirmed independent causal factor. The effect sizes are in the range of OR/RR 1.13 to 1.57—statistically relevant but clinically moderate associations.
None of the included studies directly investigated whether periodontitis therapy lowers cardiovascular risk. Randomized controlled trials (RCTs) on this issue are lacking, which represents the core gap in the scientific evidence. Without interventional data, the association remains an observation, not a directive for cardiovascular prevention.
Periodontitis therapy remains indicated from dental reasons regardless of the cardiovascular debate: preventing tooth loss, improving oral health, and improving oral health-related quality of life. The intrinsic indication for periodontitis therapy is not affected by the open question of causality.
Communicating the gum disease-cardiovascular association in dental practice has a motivating function: It can increase compliance for periodontitis therapy and aftercare. This motivational use is acceptable as long as it does not overstate the scientific evidence or give the impression that periodontitis therapy is a proven cardiovascular intervention.
Methodologically, it must be noted that the included studies vary significantly in study design, follow-up period, and population selection. This heterogeneity limits the comparability of the results and explains why pooled effect estimates must be interpreted with caution. Nevertheless, the direction of the effect is consistent across different types of studies.
For transferability to the German-speaking care context, it is also relevant that a significant portion of the scientific evidence comes from Anglo-American or Scandinavian healthcare systems. Differences in reimbursement structure, treatment culture, and patient access can influence effect sizes without invalidating the fundamental statement.
The practical consequence is clear: Treat gum disease (periodontitis)—for dental reasons. The cardiovascular association is an additional argument for the importance of oral health, but not a standalone treatment indication. Overinterpreting it as heart protection would be methodologically problematic.
For interdisciplinary collaboration, the research situation means that dentists and cardiologists should address common risk factors (smoking, diabetes, obesity), not position periodontitis therapy as a cardiovascular intervention.
In daily practice, this means: The scientific evidence does not provide a one-size-fits-all answer, but rather a framework for individualized decisions. Patient-specific factors such as general health, compliance, individual risk profiles, and treatment preferences must influence the decision.
What does this mean for you? Communication must be honest: Treat perio, yes, but do not primarily sell it as heart protection.
You may encounter this topic more often in daily life than you think. What is important here: Not every report you find in the media or on the internet accurately reflects the state of research. The studies show a more nuanced picture than sensational headlines suggest.
What makes these results reliable? In medical research, the rule is: the more independent studies that arrive at the same result, the more certain the statement. The type of study and the number of participants also play an important role. Large controlled studies with many participants provide more reliable results than small surveys.
💡 What does this mean for you?
Communication must be honest: Treat perio, yes, but do not primarily sell it as heart protection. Discuss with your next dental appointment what this specifically means for your situation.
Frequently Asked Questions
Here we answer the questions patients most frequently ask about this topic:
❓ What matters more: association or causality?
Gum disease (periodontitis) is consistently associated with increased cardiovascular risk factors. It is important to distinguish between epidemiological signal and clinical proof.
❓ What does "Biological Plausibility" mean for me as a patient?
Systemic inflammation due to gum disease (periodontitis) is biologically plausible as a risk enhancer. Plausibility is not proof—It is important to be precise here.
❓ What does "Clinical Consequence for Dentistry" mean for me as a patient?
Periodontitis therapy is medically sensible regardless of cardiovascular benefit. Communication must be honest: Treat perio, yes, but do not primarily sell it as heart protection.
❓ How certain are the results?
The scientific basis is solid, but not all questions have been definitively answered.
❓ Should I change my behavior based on this information?
Speak with your dentist before making any changes. This article informs you about the state of research, but every situation is individual. Your dentist knows your personal health situation best.
❓ Where can I learn more?
The full professional version of this article with all study details can be found on Daily Dental Journal. For personal advice, consult your dentist.
❓ What is the main message of this article?
Gum disease (periodontitis) and cardiovascular diseases are associated, not causally proven.
❓ Why are there differing opinions on this topic?
The conflict lies between the desire to position periodontitis therapy as cardiovascular prevention and the reality that intervention studies do not support this link.
🦷 When should I see the dentist?
Schedule an appointment with your dentist if:
- You are concerned about potential exposure or risk
- You are unsure if a product or substance is suitable for you
- You notice any changes in your teeth or gums
- You have questions about the topics described in this article
- It has been more than a year since your last dental visit
Important: This article does not replace a dentist's visit. It helps you go into the conversation informed.
What You Can Do Yourself
Here are concrete steps you can take as a patient:
The Most Important Thing in One Sentence
Treating gum disease (periodontitis) is always worthwhile—but not because it protects the heart, but because it protects the teeth.
Source Information
This article is based on the DDJ expert article and current scientific evidence. All statements are supported by studies fully cited in the expert article.
The content has been adapted by the DDJ editorial team for patients. Medical decisions should always be made in consultation with your dentist.
As of: March 2026 · Language: American English (en-US) · Target Audience: Patients and interested laypeople